Analysis of SARS-CoV-2 variants cultured with viral polymerase inhibitors and viral protease inhibitors revealed that resistance mutations to the antiviral agents were less likely to occur in the Omicron variant compared to the Delta variant.

https://doi.org/10.1016/j.antiviral.2023.105671